Philippe Pourquier obtained his Pharmacy degree from the University of Bordeaux (France) in 1992. Following a PhD in Biochemistry and Molecular Biology (1996) and a postdoctoral stay in the laboratory of Molecular Pharmacology at the National Cancer Institute (USA), he acquired a solid experience in the field of drug resistance to chemotherapies, in particular DNA topoisomerases inhibitors. In 2001 he obtained a senior investigator position at INSERM and was the head of the molecular pharmacology group of the INSERM U916 unit at the Bordeaux Cancer Institute, France. In 2013 he moved to the Montpellier Cancer Research Institute at INSERM U1194 where he is developing basic and translational research programs studying resistance mechanisms to drugs that are used in the treatment of colon and castration-resistant prostate cancers. These projects are developed in close collaboration with Nimes University Hospital with the aim to identify new strategies to overcome these resistance mechanisms. He has published more than 70 papers in peer-reviewed international journals including Nature Medicine and Nature Chemistry. Philippe Pourquier is the president of the scientific Council of the Regional League against Cancer and is a member of the Montpellier Faculty of Medicine.
Philippe Pourquier : Gongora Lab, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier Cedex, France